Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

A HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04120415
Recruitment Status : Not yet recruiting
First Posted : October 9, 2019
Last Update Posted : October 11, 2019
EuroVacc Foundation
European AIDS Treatment Group (EATG)
Medical Research Council
University College London, UK.
University of Liverpool
Erasmus Medical Center
Henri Mondor University Hospital
European Georges Pompidou Hospital
Saint-Louis Hospital, Paris, France
Centre Hospitalier Universitaire Vaudois
Chelsea and Westminster Hospital, UK
Universitätsklinikum Hamburg-Eppendorf
Hospital Clinic of Barcelona
Istituto Nazionale Malattie Infettive Lazaro Spallanzani
Imperial College London
Institut d'Investigacions Biomèdiques August Pi i Sunyer
European Commission
Swiss Government
Information provided by (Responsible Party):
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : June 2021
Estimated Study Completion Date : December 2021